Serum tumor markers in monitoring patients: Interpretation of results using analytical and biological variation

Anticancer Research

Volumn 16, Issue 4 B, 1996, Pages 2249-2252

  Plebani, Mario ^a,e   Giacomini, Alda ^a,e   Beghi, Luigi ^b   De Paoli, Massimo ^a,e   Roveroni, Giovanni ^a,e   Galeotti, Fabrizio ^c   Corsini, Augusto ^c   Fraser, Callum G ^d  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Department of Pediatrics   (Italy)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e Center of Biomedical Research   (Italy)

Author keywords

Analytical variability; Biological variability; Critical difference; Tumor marker

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TISSUE PLASMINOGEN ACTIVATOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

ADULT; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; MALE; NEOPLASMS; PEPTIDES; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0029788871     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Denstman F, Rosen L, Khubchandani IT, Sheets JA, Stasik JJ and Riether RD: Comparing predictive decision rules in postoperative CEA monitoring. Cancer 58: 2089-2095, 1986.
2. Ekins RP: The precision profile: its use in assay design, assessment and quality control. In: Immunoassays for Clinical Chemistry (Hunter WM and Correy JET, eds). Edinburgh, Churchill Livingstone, 1983. pp 76-105.
3. Young DS, Harris EK and Cotlove E: Biological and analytical components of variation in long term studies of serum constituents in normal subjects. IV. Result of a study designed to eliminate long term analytical deviations. Clin Chem 17: 403-410, 1971.
4. Proceedings of the Subcommitee on Analytical Goals in Clinical Chemistry (WASP): Analytical goals in clinical chemistry, their relationship to medical care. Am J Clin Pathol 71: 624-630, 1979.
5. Gion M, Mione R and Bruscagnin G: Clinical use of tumor markers. Current strategies for decision making. In: Updating on tumor markers in tissues and in biological studies (Ballesta AM, Torre GC, Bombardieri E, Gion M and Molina R. eds). Torino, Minerva Medica, 1993, pp 179-193.
6. Fraser CG, Cummings ST, Wilkinson SP, Neville RG, Knox JD, Ho O and MacWalter RS: Biological variability of 26 clinical chemistry analytes in elderly people. Clin Chem 35: 783-786, 1989.
7. Fraser CG: The application of theoretical goals based on biological variation data in proficiency testing. Arch Pathol Lab Med 112: 404-415, 1988.
8. Fraser CG, Wilkinson SP, Neville RG, Knox JD, King JF and MacWalter RS: Biological variation of common hematologic laboratory quantities in the elderly. Am J Clin Pathol 92: 465-470, 1989.
9. Harris EK: Statistical aspects of reference values in clinical pathology. Prog Clin Pathol 8: 45-66, 1981.
10. Fraser CG and Harris EK: Generation and application of data on biological variation in clinical chemistry. CRC Lab Sci 27: 409-437, 1989.
11. Fraser CG: Data on biological variation: essential prerequisites for introducing new procedures? Clin Chem 40: 1671-1673, 1994.
12. Costongs GMPH, Janson PCW, Bas BM, Hermans J, van Wersch JW and Brombacher PJ: Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem 23: 7-16, 1985.
13. Gold P and Freedman SO: Demonstration of tumor specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121: 439-462, 1965.
14. Boey J, Chung HC, Lai CK and Wang J: A prospective evaluation of serum carcynoembrionic antigen (CEA) levels in the management of colo-rectal carcinoma. World J Surg 8: 279-286, 1984.
15. Barillari P, Sammartino P, Cardi M, Ricci M, Gozzo P, Cesareo S and Cerasi A: Gastrointestinal cancer follow-up: the effectiveness of sequential CEA. TPA and CA19-9 evaluation in the early diagnosis of recurrences. Aust NZJ Surg 61: 675-680, 1991.
16. Pommier R and Waltering EA: Follow-up of patients after primary colorectal cancer resection. Seminars in surgical oncology 7: 129-132, 1991.
17. Bohm B, Schwenk W, Hucke HP and Stock W: Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma. Dis Colon Rectum 36: 280-286, 1993.
18. Sölétormos G, Nielsen D, Schiøler V, Skovsgaard T and Dombernowsky P: CA 549 in metastatic breast cancer during cytostatic treatment and follow-up. Eur J Cancer 28: 845-850, 1992.
19. Sölétormos G, Nielsen D, Schiøler V, Skovsgaard T, Winkel P, Mouridsen HT and Dombernowsky P: A novel method for monitoring high-risk breast cancer with tumor markers: CA15.3 compared to CEA and TPA. Ann Oncology 4: 861-869, 1993.
20. Sölétormos G, Schiøler V, Nielsen D, Skoévsgaard T and Dombernowsky P: Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation. Clin Chem 39: 2077-2083, 1993.